Public Profile

Boston Scientific

Boston Scientific Corporation, a leading global medical technology company, is headquartered in the United States. Founded in 1979, the company has established itself as a key player in the medical device industry, focusing on innovative solutions across various therapeutic areas, including cardiovascular, rhythm management, and urology. With a strong presence in North America, Europe, and Asia-Pacific, Boston Scientific is renowned for its advanced products and services, such as minimally invasive devices and cutting-edge imaging technologies. The company’s commitment to innovation is exemplified by its numerous milestones, including the development of the first drug-eluting stent. Recognised for its market leadership, Boston Scientific continues to push the boundaries of medical technology, enhancing patient outcomes and improving quality of life. Its dedication to research and development positions it as a trusted partner in healthcare worldwide.

DitchCarbon Score

How does Boston Scientific's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

94

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

23

Industry Benchmark

Boston Scientific's score of 94 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

Boston Scientific's reported carbon emissions

In 2024, Boston Scientific reported total carbon emissions of approximately 87,567,000 kg CO2e for Scope 1 and 9,854,000 kg CO2e for Scope 2, resulting in a combined total of about 97,421,000 kg CO2e (market-based). The company has set ambitious climate commitments, aiming for carbon neutrality in all manufacturing and key distribution sites by 2030. This pledge positions Boston Scientific as one of the first medical device manufacturers to undertake such a commitment. Since 2009, Boston Scientific has achieved a significant reduction of 68% in greenhouse gas emissions for both Scope 1 and Scope 2. For the near term, the company targets a 46.2% absolute reduction in Scope 1 and 2 emissions by 2030, using 2019 as the baseline year. Additionally, Boston Scientific aims to reduce Scope 3 emissions—covering areas such as purchased goods and services, capital goods, and business travel—by 55% per USD value added within the same timeframe. Looking towards the long term, Boston Scientific has committed to a 97% reduction in Scope 1 and 2 emissions per USD value added by 2050, which equates to a 90% absolute reduction from the 2019 baseline. The company also plans to achieve a similar 97% reduction in Scope 3 emissions by 2050. These initiatives reflect Boston Scientific's dedication to sustainability and its proactive approach to addressing climate change within the healthcare equipment and supplies sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2015201620172018201920202021202220232024
Scope 1
-
-
-
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
-
-
-
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
0,000,000
Scope 3
-
-
-
-
0,000,000,000
-
-
0,000,000,000
0,000,000,000
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Boston Scientific's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Boston Scientific is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Boston Scientific is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

B. Braun Melsungen AG

DE
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 months ago

Getinge

SE
Health and social work services (85)
Updated about 8 hours ago

Elekta

SE
Health and social work services (85)
Updated 24 days ago

Baxter

US
Health and social work services (85)
Updated 9 days ago

St. Jude Medical, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 months ago
DitchCarbon Score

Danaher Corporation

US
Chemicals nec
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers